Document Detail

Modulation of Bcl-2-related protein expression in pancreatic beta cells by pro-inflammatory cytokines and its dependence on the antioxidative defense status.
MedLine Citation:
PMID:  20933054     Owner:  NLM     Status:  In-Process    
Pro-inflammatory cytokines are key mediators in the selective and progressive destruction of insulin-producing beta cells during type 1 diabetes development. However, the mechanisms of cytokine-induced beta cell apoptosis are not fully understood. This study demonstrates that pro-inflammatory cytokines strongly modified the expression of the anti-apoptotic protein Bcl-2 and the pro-apoptotic BH3-only proteins Bad, Bim, and Bid in primary rat islets and insulin-producing RINm5F cells. Overexpression of mitochondrially located catalase (MitoCatalase) specifically increased basal Bcl-2 and decreased basal Bax expression, suppressed cytokine-mediated reduction of Bcl-2, and thereby prevented the release of cytochrome c, Smac/DIABLO and the activation of caspase-9 and -3. Thus, cytokine-mediated decrease of Bcl-2 expression and the sequentially changed Bax/Bcl-2 ratio are responsible for the release of pro-apoptotic mitochondrial factors, activation of caspase-9, and ultimately caspase-3. These results indicate that activation of the intrinsic/mitochondrial apoptosis pathway is essential for cytokine-induced beta cell death and the mitochondrial generation of reactive oxygen species, in particular mitochondrial hydrogen peroxide, differentially regulates the Bax/Bcl-2 ratio.
Ilir Mehmeti; Sigurd Lenzen; Stephan Lortz
Related Documents :
15380674 - Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyo...
12637494 - Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally ...
12778384 - Egf receptor signaling affects bcl-2 family gene expression and apoptosis after massive...
19027294 - Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective bcl-2 inhibitors.
7959464 - Immunotoxicity of silicone: implications of oxidant balance towards adjuvant activity.
23675964 - Immunotherapy with dendritic cells as a cancer treatment: perspectives and therapeutic ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-10-07
Journal Detail:
Title:  Molecular and cellular endocrinology     Volume:  332     ISSN:  1872-8057     ISO Abbreviation:  Mol. Cell. Endocrinol.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7500844     Medline TA:  Mol Cell Endocrinol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  88-96     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Institute of Clinical Biochemistry, Hannover Medical School, 30623 Hannover, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Endogenously elevated androgens alter the developmental programming of the hypothalamic-pituitary ax...
Next Document:  Age related strategic differences in processing irrelevant information.